These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38347540)

  • 1. IDH2/R140Q mutation confers cytokine-independent proliferation of TF-1 cells by activating constitutive STAT3/5 phosphorylation.
    Yang J; Chen J; Chang J; Sun X; Wei Q; Cai X; Cao P
    Cell Commun Signal; 2024 Feb; 22(1):116. PubMed ID: 38347540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M and STAT3 Signaling Pathways Support Human Trophoblast Differentiation by Inhibiting Inflammatory Stress in Response to IFN╬│ and GM-CSF.
    Ravelojaona M; Girouard J; Kana Tsapi ES; Chambers M; Vaillancourt C; Van Themsche C; Thornton CA; Reyes-Moreno C
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells.
    Chen J; Yang J; Wei Q; Weng L; Wu F; Shi Y; Cheng X; Cai X; Hu C; Cao P
    Cell Commun Signal; 2020 Apr; 18(1):55. PubMed ID: 32245484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale integrated analysis to identify prospective molecular mechanisms and therapeutic targets in isocitrate dehydrogenase 2 R140Q-mutated acute myeloid leukemia.
    Huang R; Liao X; Li J; Wei J; Su X; Lai X; Liu B; Zhu F; Huang Y; Li Q
    Oncol Rep; 2019 May; 41(5):2876-2888. PubMed ID: 30896832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation.
    Wang Y; Cai D; Brendel C; Barett C; Erben P; Manley PW; Hochhaus A; Neubauer A; Burchert A
    Blood; 2007 Mar; 109(5):2147-55. PubMed ID: 17090651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant
    Goldberg L; Negi V; Chung YJ; Onozawa M; Zhu YJ; Walker RL; Pierce R; Patel DP; Krausz KW; Gonzalez FJ; Goodell MA; Rodriguez BAT; Meltzer PS; Aplan PD
    Cancer Res; 2021 Oct; 81(19):5033-5046. PubMed ID: 34321240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor.
    Bovolenta C; Pilotti E; Mauri M; Turci M; Ciancianaini P; Fisicaro P; Bertazzoni U; Poli G; Casoli C
    Blood; 2002 Jan; 99(1):224-31. PubMed ID: 11756175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines.
    Gu L; Chiang KY; Zhu N; Findley HW; Zhou M
    Exp Hematol; 2007 Jun; 35(6):957-66. PubMed ID: 17533050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours.
    Zhang X; Blaskovich MA; Forinash KD; Sebti SM
    Br J Cancer; 2014 Aug; 111(5):894-902. PubMed ID: 24983364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
    Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
    J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
    Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
    J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants.
    Gao M; Zhu H; Fu L; Li Y; Bao X; Fu H; Quan H; Wang L; Lou L
    Cancer Sci; 2019 Oct; 110(10):3306-3314. PubMed ID: 31361380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
    Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
    Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia.
    Ogawara Y; Katsumoto T; Aikawa Y; Shima Y; Kagiyama Y; Soga T; Matsunaga H; Seki T; Araki K; Kitabayashi I
    Cancer Res; 2015 May; 75(10):2005-16. PubMed ID: 25795706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
    Hoyle PE; Steelman LS; McCubrey JA
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
    Drexler HG; Zaborski M; Quentmeier H
    Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor regulates the activation of inflammatory signals in macrophages and trophoblast cells.
    Hamelin-Morrissette J; Dallagi A; Girouard J; Ravelojaona M; Oufqir Y; Vaillancourt C; Van Themsche C; Carrier C; Reyes-Moreno C
    Mol Immunol; 2020 Apr; 120():32-42. PubMed ID: 32045772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
    Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
    Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.